Latest news

06 Feb 2018
Idorsia announces financial results for 2017 - company off to a great start - 4 compounds to enter Phase 3 development
20 Dec 2017
Idorsia forms research collaboration with Roche in the field of cancer immunotherapy
04 Dec 2017
Idorsia announces collaboration with Janssen Biotech on aprocitentan (ACT-132577)
24 Oct 2017
Idorsia announces financial results as of 30 September 2017
03 Aug 2017
Idorsia announces half year results for 2017 - successful start of new biopharmaceutical company
28 Jul 2017
ACT-541468 (DORA) meets primary endpoint in Phase 2 program in adult and elderly patients with insomnia
16 Jun 2017
Idorsia - Reaching out for more